Old Web
English
Sign In
Acemap
>
authorDetail
>
Suzanne Arulogun
Suzanne Arulogun
University College London Hospitals NHS Foundation Trust
Medicine
B cell
Vaccination
Daratumumab
Immunology
3
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies.
2021
British Journal of Haematology
Thomas A. Fox
Amy A Kirkwood
Louise Enfield
Maeve A OReilly
Suzanne Arulogun
Shirley DSa
Jenny ONions
Janki Kavi
Evan Vitsaras
William Townsend
Siobhan O. Burns
Satyen H. Gohil
Kate Cwynarski
Kirsty Thomson
Mahdad Noursadeghi
Robert S. Heyderman
Tommy Rampling
Kirit M. Ardeshna
Laura E. McCoy
Emma C. Morris
Show All
Source
Cite
Save
Citations (1)
Low seropositivity and sub-optimal neutralisation rates in patients fully vaccinated against COVID-19 with B cell malignancies.
2021
medRxiv
Thomas A. Fox
AA Kirkwood
L Enfield
Maeve A OReilly
Suzanne Arulogun
Shirley DSa
Jenny ONions
J Kavi
E Vitsaras
William Townsend
Siobhan O. Burns
SH Gohil
Kate Cwynarski
Kirsty Thomson
Mahdad Noursadeghi
Robert S. Heyderman
Tommy Rampling
Kirit M. Ardeshna
Laura E. McCoy
Emma C. Morris
Show All
Source
Cite
Save
Citations (0)
Daratumumab for disabling cold agglutinin disease refractory to B-cell directed therapy.
2020
American Journal of Hematology
Oliver Tomkins
Sigbjørn Berentsen
Suzanne Arulogun
Mallika Sekhar
Shirley DSa
Show All
Source
Cite
Save
Citations (3)
1